Cellular Organization and Cytoskeletal Regulation of the Hippo Signaling Network

Trends in Cell Biology

Volumn 26, Issue 9, 2016, Pages 694-704

  Sun, Shuguo ^a   Irvine, Kenneth D ^a  

^a RUTGERS UNIVERSITY   (United States)

Author keywords

cell junctions; cytoskeleton; Hippo; mechanical force; signaling

Indexed keywords

F ACTIN; ACTIN; PROTEIN SERINE THREONINE KINASE;

CELL CONTACT; CELL EXPANSION; CELL FATE; CELL INTERACTION; CELL JUNCTION; CELL POLARITY; CELLULAR DISTRIBUTION; CYTOSKELETON; EXTRACELLULAR MATRIX; HIPPO SIGNALING NETWORK; HUMAN; INTRACELLULAR SIGNALING; NONHUMAN; PRIORITY JOURNAL; REGULATORY MECHANISM; REVIEW; ANIMAL; METABOLISM; SIGNAL TRANSDUCTION;

ACTINS; ANIMALS; CYTOSKELETON; EXTRACELLULAR MATRIX; HUMANS; INTERCELLULAR JUNCTIONS; PROTEIN-SERINE-THREONINE KINASES; SIGNAL TRANSDUCTION;

EID: 84971654994     PISSN: 09628924     EISSN: 18793088     Source Type: Journal    
DOI: 10.1016/j.tcb.2016.05.003     Document Type: Review

References (118)

1. 1 Reddy, B.V., Irvine, K.D., The Fat and Warts signaling pathways: new insights into their regulation, mechanism and conservation. Development 135 (2008), 2827–2838.
2. 2 Harvey, K.F., et al. The Hippo pathway and human cancer. Nat. Rev. Cancer 13 (2013), 246–257.
3. 3 Yu, F-X., et al. Hippo pathway in organ size control, tissue homeostasis, and cancer. Cell 163 (2015), 811–828.
4. 4 Santinon, G., et al. Control of YAP/TAZ activity by metabolic and nutrient-sensing pathways. Trends Bell Biol. 26 (2015), 289–299.
5. 5 Irvine, K.D., Harvey, K.F., Control of organ growth by patterning and Hippo signaling in Drosophila. Cold Spring Harb. Perspect. Biol., 7, 2015, a019224.
6. 6 Oh, H., Irvine, K.D., In vivo regulation of Yorkie phosphorylation and localization. Development 135 (2008), 1081–1088.
7. 7 Dong, J., et al. Elucidation of a universal size-control mechanism in Drosophila and mammals. Cell 130 (2007), 1120–1133.
8. 8 Huang, J., et al. The Hippo signaling pathway coordinately regulates cell proliferation and apoptosis by inactivating Yorkie, the Drosophila homolog of YAP. Cell 122 (2005), 421–434.
9. 9 Oh, H., et al. Yorkie promotes transcription by recruiting a histone methyltransferase complex. Cell Rep. 8 (2014), 449–459.
10. 10 Oh, H., et al. Genome-wide association of Yorkie with chromatin and chromatin-remodeling complexes. Cell Rep. 3 (2013), 309–318.
11. 11 Qing, Y., et al. The Hippo effector Yorkie activates transcription by interacting with a histone methyltransferase complex through Ncoa6. Elife, 2014, e02564.
12. 12 Wu, S., et al. hippo encodes a Ste-20 family protein kinase that restricts cell proliferation and promotes apoptosis in conjunction with Salvador and Warts. Cell 114 (2003), 445–456.
13. 13 Udan, R.S., et al. Hippo promotes proliferation arrest and apoptosis in the Salvador/Warts pathway. Nat. Cell Biol. 5 (2003), 914–920.
14. 14 Pantalacci, S., et al. The Salvador partner Hippo promotes apoptosis and cell-cycle exit in Drosophila. Nat. Cell Biol. 5 (2003), 921–927.
15. 15 Jia, J., et al. The Drosophila Ste20 family kinase dMST functions as a tumor suppressor by restricting cell proliferation and promoting apoptosis. Genes Dev. 17 (2003), 2514–2519.
16. 16 Harvey, K.F., et al. The Drosophila Mst ortholog, Hippo, restricts growth and cell proliferation and promotes apoptosis. Cell 114 (2003), 457–467.
17. 17 Cho, E., et al. Delineation of a Fat tumor suppressor pathway. Nat. Genet. 38 (2006), 1142–1150.
18. 18 Sun, S., et al. Localization of Hippo signaling complexes and Warts activation in vivo. Nat. Commun., 6, 2015, 8402.
19. 19 Yin, F., et al. Spatial organization of Hippo signaling at the plasma membrane mediated by the tumor suppressor Merlin/NF2. Cell 154 (2013), 1342–1355.
20. 20 Rauskolb, C., et al. Cytoskeletal tension inhibits Hippo signaling through an Ajuba–Warts complex. Cell 158 (2014), 143–156.
21. 21 Rauskolb, C., et al. Zyxin links fat signaling to the Hippo pathway. PLoS Biol., 9, 2011, e1000624.
22. 22 Das Thakur, M., et al. Ajuba LIM proteins are negative regulators of the Hippo signaling pathway. Curr. Biol. 20 (2010), 657–662.
23. 23 Lai, Z.C., et al. Control of cell proliferation and apoptosis by Mob as tumor suppressor. Mats. Cell 120 (2005), 675–685.
24. 24 Vrabioiu, A.M., Struhl, G., Fat/Dachsous signaling promotes Drosophila wing growth by regulating the conformational state of the NDR kinase Warts. Dev. Cell 35 (2015), 737–749.
25. 25 Tapon, N., et al. salvador promotes both cell cycle exit and apoptosis in Drosophila and is mutated in human cancer cell lines. Cell 110 (2002), 467–478.
26. 26 Kango-Singh, M., et al. Shar-pei mediates cell proliferation arrest during imaginal disc growth in Drosophila. Development 129 (2002), 5719–5730.
27. 27 Salah, Z., et al. NEDD4 E3 ligase inhibits the activity of the Hippo pathway by targeting LATS1 for degradation. Cell Cycle 12 (2013), 3817–3823.
28. 28 Yeung, B., et al. WWP1 E3 ligase targets LATS1 for ubiquitin-mediated degradation in breast cancer cells. PLoS ONE, 8, 2013, e61027.
29. 29 Ho, K.C., et al. Itch E3 ubiquitin ligase regulates large tumor suppressor 1 stability [corrected]. Proc. Natl Acad. Sci. U. S. A. 108 (2011), 4870–4875.
30. 30 Salah, Z., et al. Negative regulation of the Hippo pathway by E3 ubiquitin ligase ITCH is sufficient to promote tumorigenicity. Cancer Res. 71 (2011), 2010–2020.
31. 31 Bae, S.J., et al. NEDD4 controls intestinal stem cell homeostasis by regulating the Hippo signalling pathway. Nat. Commun., 6, 2015, 6314.
32. 32 Ma, B., et al. Hypoxia regulates Hippo signalling through the SIAH2 ubiquitin E3 ligase. Nat. Cell Biol. 17 (2015), 95–103.
33. 33 Zhang, L., et al. NDR functions as a physiological YAP1 kinase in the intestinal epithelium. Curr. Biol. 25 (2015), 296–305.
34. 34 Li, S., et al. Overlapping functions of the MAP4K family kinases Hppy and Msn in Hippo signaling. Cell Discov., 1, 2015, 15038.
35. 35 Li, Q., et al. The conserved Misshapen–Warts–Yorkie pathway acts in enteroblasts to regulate intestinal stem cells in Drosophila. Dev. Cell 31 (2014), 291–304.
36. 36 Zheng, Y., et al. Identification of Happyhour/MAP4K as alternative Hpo/Mst-like kinases in the Hippo kinase cascade. Dev. Cell 34 (2015), 642–655.
37. 37 Meng, Z., et al. MAP4K family kinases act in parallel to MST1/2 to activate LATS1/2 in the Hippo pathway. Nat. Commun., 6, 2015, 8357.
38. 38 Cai, J., et al. β-Catenin destruction complex-independent regulation of Hippo–YAP signaling by APC in intestinal tumorigenesis. Genes Dev. 29 (2015), 1493–1506.
39. 39 Dent, L.G., et al. The GTPase regulatory proteins Pix and Git control tissue growth via the Hippo pathway. Curr. Biol. 25 (2015), 124–130.
40. 40 Arash, E.H., et al. Arhgef7 promotes activation of the Hippo pathway core kinase Lats. EMBO J. 33 (2014), 2997–3011.
41. 41 Chung, H-L., et al. Drosophila Schip1 links Expanded and Tao-1 to regulate Hippo signaling. Dev. Cell 36 (2016), 511–524.
42. 42 Poon, C.L.C., et al. The sterile 20-like kinase Tao-1 controls tissue growth by regulating the Salvador–Warts–Hippo pathway. Dev. Cell 21 (2011), 896–906.
43. 43 Boggiano, J.C., et al. Tao-1 phosphorylates Hippo/MST kinases to regulate the Hippo–Salvador–Warts tumor suppressor pathway. Dev. Cell 21 (2011), 888–895.
44. 44 Tepass, U., et al. crumbs encodes an EGF-like protein expressed on apical membranes of Drosophila epithelial cells and required for organization of epithelia. Cell 61 (1990), 787–799.
45. 45 Ma, D., et al. Fidelity in planar cell polarity signalling. Nature 421 (2003), 543–547.
46. 46 McCartney, B.M., et al. The neurofibromatosis-2 homologue, Merlin, and the tumor suppressor Expanded function together in Drosophila to regulate cell proliferation and differentiation. Development 127 (2000), 1315–1324.
47. 47 Deng, Y., et al. Hippo activation through homodimerization and membrane association for growth inhibition and organ size control. Dev. Biol. 375 (2013), 152–159.
48. 48 Hergovich, A., et al. The human tumour suppressor LATS1 is activated by human MOB1 at the membrane. Biochem. Biophys. Res. Commun. 345 (2006), 50–58.
49. 49 Ho, L.L., et al. Mob as tumor suppressor is activated at the cell membrane to control tissue growth and organ size in Drosophila. Dev. Biol. 337 (2010), 274–283.
50. 50 Yue, T., et al. The cell adhesion molecule Echinoid functions as a tumor suppressor and upstream regulator of the Hippo signaling pathway. Dev. Cell 22 (2012), 255–267.
51. 51 Islam, R., et al. Neuroglian activates Echinoid to antagonize the Drosophila EGF receptor signaling pathway. Development 130 (2003), 2051–2059.
52. 52 Grzeschik, N.A., et al. Lgl, aPKC, and Crumbs regulate the Salvador/Warts/Hippo pathway through two distinct mechanisms. Curr. Biol. 20 (2010), 573–581.
53. 53 Chen, C.L., et al. The apical–basal cell polarity determinant Crumbs regulates Hippo signaling in Drosophila. Proc. Natl Acad. Sci. U. S. A. 107 (2010), 15810–15815.
54. 54 Ding, R., et al. The Hippo signalling pathway maintains quiescence in Drosophila neural stem cells. Nat. Commun., 7, 2016, 10510.
55. 55 Robinson, B.S., et al. Crumbs regulates Salvador/Warts/Hippo signaling in Drosophila via the FERM-domain protein Expanded. Curr. Biol. 20 (2010), 582–590.
56. 56 Ling, C., et al. The apical transmembrane protein Crumbs functions as a tumor suppressor that regulates Hippo signaling by binding to Expanded. Proc. Natl Acad. Sci. U. S. A. 107 (2010), 10532–10537.
57. 57 Yang, C-C., et al. Differential regulation of the Hippo pathway by adherens junctions and apical–basal cell polarity modules. Proc. Natl Acad. Sci. U. S. A. 112 (2015), 1785–1790.
58. 58 Yu, J., et al. Kibra functions as a tumor suppressor protein that regulates Hippo signaling in conjunction with Merlin and Expanded. Dev. Cell 18 (2010), 288–299.
59. 59 Genevet, A., et al. Kibra is a regulator of the Salvador/Warts/Hippo signalling network. Dev. Cell 18 (2010), 300–308.
60. 60 Baumgartner, R., et al. The WW domain protein Kibra acts upstream of Hippo in Drosophila. Dev. Cell 18 (2010), 309–316.
61. 61 Xiao, L., et al. KIBRA regulates Hippo signaling activity via interactions with large tumor suppressor kinases. J. Biol. Chem. 286 (2011), 7788–7796.
62. 62 Li, W., et al. Merlin/NF2 loss-driven tumorigenesis linked to CRL4(DCAF1)-mediated inhibition of the Hippo pathway kinases Lats1 and 2 in the nucleus. Cancer Cell 26 (2014), 48–60.
63. 63 Li, W., et al. Merlin/NF2 suppresses tumorigenesis by inhibiting the E3 ubiquitin ligase CRL4(DCAF1) in the nucleus. Cell 140 (2010), 477–490.
64. 64 Schlegelmilch, K., et al. Yap1 acts downstream of α-catenin to control epidermal proliferation. Cell 144 (2011), 782–795.
65. 65 Kim, N.G., et al. E-cadherin mediates contact inhibition of proliferation through Hippo signaling-pathway components. Proc. Natl Acad. Sci. U. S. A. 108 (2011), 11930–11935.
66. 66 Gladden, A.B., et al. The NF2 tumor suppressor, Merlin, regulates epidermal development through the establishment of a junctional polarity complex. Dev. Cell 19 (2010), 727–739.
67. 67 Yi, C., et al. A tight junction-associated Merlin–Angiomotin complex mediates Merlin's regulation of mitogenic signaling and tumor suppressive functions. Cancer Cell 19 (2011), 527–540.
68. 68 Li, P., et al. αE-catenin inhibits a Src–YAP1 oncogenic module that couples tyrosine kinases and the effector of Hippo signaling pathway. Genes Dev., 2016 Published online March 24, 2016 http://dx.doi.org/10.1101/gad.274951.115.
69. 69 Mao, Y., et al. Fat4/Dchs1 signaling between stromal and cap mesenchyme cells influences nephrogenesis and ureteric bud branching. Development 142 (2015), 2474–2585.
70. 70 Bagherie-Lachidan, M., et al. Stromal Fat4 acts non-autonomously with Dachsous1/2 to restrict the nephron progenitor pool. Development 142 (2015), 2564–2573.
71. 71 Das, A., et al. Stromal–epithelial crosstalk regulates kidney progenitor cell differentiation. Nat. Cell Biol. 15 (2013), 1035–1044.
72. 72 Bossuyt, W., et al. An evolutionary shift in the regulation of the Hippo pathway between mice and flies. Oncogene 33 (2014), 1218–1228.
73. 73 Varelas, X., et al. The Crumbs complex couples cell density sensing to Hippo-dependent control of the TGF-β–SMAD pathway. Dev. Cell 19 (2010), 831–844.
74. 74 Szymaniak, A.D., et al. Crumbs3-mediated polarity directs airway epithelial cell fate through the Hippo pathway effector Yap. Dev. Cell 34 (2015), 283–296.
75. 75 Angus, L., et al. Willin/FRMD6 expression activates the Hippo signaling pathway kinases in mammals and antagonizes oncogenic YAP. Oncogene 31 (2012), 238–250.
76. 76 Moleirinho, S., et al. The Angiomotins–from discovery to function. FEBS Lett. 588 (2014), 2693–2703.
77. 77 Zhao, B., et al. Angiomotin is a novel Hippo pathway component that inhibits YAP oncoprotein. Genes Dev. 25 (2011), 51–63.
78. 78 Paramasivam, M., et al. Angiomotin family proteins are novel activators of the LATS2 kinase tumor suppressor. Mol. Biol. Cell 22 (2011), 3725–3733.
79. 79 Chan, S.W., et al. Hippo pathway-independent restriction of TAZ and YAP by Angiomotin. J Biol. Chem. 286 (2011), 7018–7026.
80. 80 Wang, W., et al. Angiomotin-like proteins associate with and negatively regulate YAP1. J. Biol. Chem. 286 (2011), 4364–4370.
81. 81 Oh, H., et al. Phosphorylation-independent repression of Yorkie in Fat–Hippo signaling. Dev. Biol. 335 (2009), 188–197.
82. 82 Badouel, C., et al. The FERM-domain protein Expanded regulates Hippo pathway activity via direct interactions with the transcriptional activator Yorkie. Dev. Cell 16 (2009), 411–420.
83. 83 Dai, X., et al. Phosphorylation of Angiomotin by Lats1/2 kinases inhibits F-actin binding, cell migration, and angiogenesis. J. Biol. Chem. 288 (2013), 34041–34051.
84. 84 Chan, S.W., et al. Actin-binding and cell proliferation activities of Angiomotin family members are regulated by Hippo pathway-mediated phosphorylation. J. Biol. Chem. 288 (2013), 37296–37307.
85. 85 Adler, J.J., et al. Serum deprivation inhibits the transcriptional co-activator YAP and cell growth via phosphorylation of the 130-kDa isoform of Angiomotin by the LATS1/2 protein kinases. Proc. Natl Acad. Sci. U. S. A. 110 (2013), 17368–17373.
86. 86 Hirate, Y., et al. Polarity-dependent distribution of Angiomotin localizes Hippo signaling in preimplantation embryos. Curr. Biol. 23 (2013), 1181–1194.
87. 87 Li, Y., et al. Angiomotin binding-induced activation of Merlin/NF2 in the Hippo pathway. Cell Res. 25 (2015), 801–817.
88. 88 Sasaki, H., Position- and polarity-dependent Hippo signaling regulates cell fates in preimplantation mouse embryos. Semin. Cell Dev. Biol 47-48 (2015), 80–87.
89. 89 Nishioka, N., et al. The Hippo signaling pathway components Lats and Yap pattern Tead4 activity to distinguish mouse trophectoderm from inner cell mass. Dev. Cell 16 (2009), 398–410.
90. 90 Leung, C.Y., Zernicka-Goetz, M., Angiomotin prevents pluripotent lineage differentiation in mouse embryos via Hippo pathway-dependent and -independent mechanisms. Nat. Commun., 4, 2013, 2251.
91. 91 Zhao, B., et al. Cell detachment activates the Hippo pathway via cytoskeleton reorganization to induce anoikis. Genes Dev. 26 (2012), 54–68.
92. 92 Wada, K-I., et al. Hippo pathway regulation by cell morphology and stress fibers. Development 138 (2011), 3907–3914.
93. 93 Dupont, S., et al. Role of YAP/TAZ in mechanotransduction. Nature 474 (2011), 179–183.
94. 94 Serrano, I., et al. Inactivation of the Hippo tumour suppressor pathway by integrin-linked kinase. Nat. Commun., 4, 2013, 2976.
95. 95 Kim, N-G., Gumbiner, B.M., Adhesion to fibronectin regulates Hippo signaling via the FAK–Src–PI3K pathway. J. Cell Biol. 210 (2015), 503–515.
96. 96 Fan, R., et al. Regulation of Hippo pathway by mitogenic growth factors via phosphoinositide 3-kinase and phosphoinositide-dependent kinase-1. Proc. Natl Acad. Sci. U. S. A. 110 (2013), 2569–2574.
97. 97 Seong, J., et al. Distinct biophysical mechanisms of focal adhesion kinase mechanoactivation by different extracellular matrix proteins. Proc. Natl Acad. Sci. U. S. A. 110 (2013), 19372–19377.
98. 98 Taniguchi, K., et al. A gp130–Src–YAP module links inflammation to epithelial regeneration. Nature 519 (2015), 57–62.
99. 99 Sansores-Garcia, L., et al. Modulating F-actin organization induces organ growth by affecting the Hippo pathway. EMBO J. 30 (2011), 2325–2335.
100. 100 Fernández, B.G., et al. Actin-capping protein and the Hippo pathway regulate F-actin and tissue growth in Drosophila. Development 138 (2011), 2337–2346.
101. 101 Aragona, M., et al. A mechanical checkpoint controls multicellular growth through YAP/TAZ regulation by actin-processing factors. Cell 154 (2013), 1047–1059.
102. 102 Mateus, R., et al. Control of tissue growth by Yap relies on cell density and F-actin in zebrafish fin regeneration. Development 142 (2015), 2752–2763.
103. 103 Yu, F-X., et al. Regulation of the Hippo–YAP pathway by G-protein-coupled receptor signaling. Cell 150 (2012), 780–791.
104. 104 Gaspar, P., et al. Zyxin antagonizes the FERM protein Expanded to couple F-actin and Yorkie-dependent organ growth. Curr. Biol. 25 (2015), 679–689.
105. 105 Mana-Capelli, S., et al. Angiomotins link F-actin architecture to Hippo pathway signaling. Mol. Biol. Cell 25 (2014), 1676–1685.
106. 106 Kim, M., et al. cAMP/PKA signalling reinforces the LATS–YAP pathway to fully suppress YAP in response to actin cytoskeletal changes. EMBO J. 32 (2013), 1543–1555.
107. 107 Codelia, V.A., et al. Regulation of YAP by mechanical strain through Jnk and Hippo signaling. Curr. Biol. 24 (2014), 2012–2017.
108. 108 Enomoto, M., et al. JNK signaling is converted from anti- to pro-tumor pathway by Ras-mediated switch of Warts activity. Dev. Biol. 403 (2015), 162–171.
109. 109 Sun, G., Irvine, K.D., Regulation of Hippo signaling by Jun kinase signaling during compensatory cell proliferation and regeneration, and in neoplastic tumors. Dev. Biol. 350 (2011), 139–151.
110. 110 Chen, C-L., et al. Tumor suppression by cell competition through regulation of the Hippo pathway. Proc. Natl Acad. Sci. U. S. A. 109 (2012), 484–489.
111. 111 Sun, G., Irvine, K.D., Ajuba family proteins link JNK to Hippo signaling. Sci. Signal., 6, 2013, ra81.
112. 112 Driscoll, T.P., et al. Cytoskeletal to nuclear strain transfer regulates YAP signaling in mesenchymal stem cells. Biophys. J. 108 (2015), 2783–2793.
113. 113 Benham-Pyle, B.W., et al. Cell adhesion. Mechanical strain induces E-cadherin-dependent Yap1 and β-catenin activation to drive cell cycle entry. Science 348 (2015), 1024–1027.
114. 114 Yonemura, S., et al. α-Catenin as a tension transducer that induces adherens junction development. Nat. Cell Biol. 12 (2010), 533–542.
115. 115 Wong, K.K.L., et al. β-Spectrin regulates the Hippo signaling pathway and modulates the basal actin network. J. Biol. Chem. 290 (2015), 6397–6407.
116. 116 Fletcher, G.C., et al. The Spectrin cytoskeleton regulates the Hippo signalling pathway. EMBO J. 34 (2015), 940–954.
117. 117 Deng, H., et al. Spectrin regulates Hippo signaling by modulating cortical actomyosin activity. Elife, 4, 2015, e06567.
118. 118 Cockburn, K., et al. The Hippo pathway member Nf2 is required for inner cell mass specification. Curr. Biol. 23 (2013), 1195–1201.